August 2016 Newsletter

August 24, 2016:

Surgeons at ASRS Meeting Praise Advances, Criticize Costs in Retina

The conference drew record attendance, with an unofficial total of 1,902.

August 24, 2016:

Alcon Gains Quick Approval of CyPass Stent for Glaucoma

The company acquired the technology in February for an undisclosed amount.

August 24, 2016:

Mazzo Describes His New Leadership Role at Carl Zeiss Meditec

Industry veteran said he will consolidate the firm’s ophthalmic business efforts under one strategy.

August 24, 2016:

Allergan Boosts Sales of Restasis to Fend Off Shire’s Xiidra

The dry eye treatment’s net revenues jumped 20 percent year over year.

August 24, 2016:

Shire Prices Xiidra on Par with Restasis in US Dry Eye Market

A spokesman for the company confirmed that the list price of Xiidra for a 30-day supply is $426.73.

August 24, 2016:

Allergan Acquires ForSight VISION5, Developer of Periocular Ring for Glaucoma

The deal calls for $95 million up front, plus a milestone payment.

August 24, 2016:

2016 ASRS Meeting: Presenters Highlight OCT Angiography, Vitrectomy Technology

Products featured in the exhibit hall included the TrueVision 3D heads-up display at Alcon’s booth and new surgical instruments shown by Bausch + Lomb.

August 24, 2016:

2016 ASRS Meeting: Antioxidant Supplements May Raise Risk of AMD in Some Patients, Researchers Find

Study found that patients were affected differently based on their genotype.

August 24, 2016:

2016 ASRS Meeting: Patients with Retinal Implants Learn New Kind of Sight

The Argus II makes it possible to see squares, moving lines, and alternating bands of light and dark.

August 24, 2016:

2016 ASRS Meeting: Phase IV Study Clarifies Patient Selection for Jetrea; Other Approaches Discussed

Patient selection makes a difference in the efficacy of the treatment in VMA, Mathew MacCumber said.

August 24, 2016:

OIS Launches Retina Meeting at ASRS Conference; 240 Attend

The half-day forum featured 44 speakers, with presentations by 16 companies.

August 24, 2016:

Ophthalmologist Treats Pellet Wounds Following Kashmir Unrest

In late July, Prof. Dr. S. Natarajan of India performed 41 surgeries in two and a half days.

August 24, 2016:

EURETINA/ESCRS Meeting Promises Latest Ophthalmic Technology

Biennial joint conference will be held in mid-September in Copenhagen, Denmark.

August 24, 2016:

Market Report: MIGS Devices Continue to Transform Glaucoma Surgery Market

The segment is expected to grow at a compounded rate of nearly 27 percent over the next five years.

August 24, 2016:

Market Report: Glaucoma Pharma Market Begins to Rebound with Combo Drugs, Sustained Delivery Devices

The segment is expected to grow at a rate of 5.4 percent over the next five years as new products are commercialized.

August 24, 2016:

Valeant Makes Bausch + Lomb a Reportable Segment Led by Ari Kellen

The segment is expected to grow 6 to 8 percent through 2018.

August 24, 2016:

Alcon Sales Decline 2 Percent in Q2-2016

The firm marked two milestones, receiving CE marking in Europe for its Dailies Total1 Multifocal and PanOptix trifocal IOL with UltraSert.

August 24, 2016:

August 2016 Earnings Briefs

August 24, 2016:

Study: LASIK Has Better Long-term Satisfaction Rate, Safety Profile than Contact Lenses

While interim results were presented at the 2014 AAO meeting, the latest results looked at three-year follow-up.

August 24, 2016:

Pixium Vision Gains CE Marking for IRIS II Artificial Vision System

The company is the third to begin commercialization of a retinal implant-based artificial vision system.

August 24, 2016:

August 2016 News Briefs

Social media